Meleis' Transition Theory-Based Education and Counseling Program in Menopausal Women

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-55
SponsorAnkara Medipol University

About this trial

This randomized controlled trial aims to evaluate the effectiveness of a Meleis' Transition Theory-based education and counseling program on menopausal symptoms, perimenopausal depression, and menopause-specific quality of life among naturally menopausal women aged 45 to 55 years.

Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured four-week education and counseling program based on Meleis' Transition Theory, supported by a secure online messaging group and follow-up counseling sessions. The control group will receive routine care and standard information during the study period and will be offered a one-day educational session after completion of the final assessment.

The outcomes will be measured at baseline and Week 16 using the Menopause Rating Scale, the Perimenopausal Depression Scale, and the Menopause-Specific Quality of Life Questionnaire-II.

Eligibility criteria

Qualifiers

Female participants aged 45 to 55 years

Naturally menopausal women

Menopause duration not exceeding 2 years

Experiencing menopausal symptoms

Disqualifiers

Failure to continue participation in the study

Failure to attend education and counseling sessions

Withdrawal from the study at any time

Withdrawal of informed consent

Trial design

Treatments tested in this trial

  • Meleis' Transition Theory-Based Education and Counseling Program
  • Standard Information

Treatment groups

114 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ankara Medipol University

Lead sponsor

Gulhane School of Nursing

Collaborator